Skip to main content


Fig. 1 | Journal of Neuroinflammation

Fig. 1

From: Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson’s disease

Fig. 1

Lenalidomide reduces motor behavioral deficits in mThy1-α-syn tg mice. Non-tg and tg animals treated with either vehicle, lenalidomide, or thalidomide were analyzed in the open field and round beam tests. a Total activity, measured as total beam breaks. b Thigmotaxis, measured as the percentage of time spent in the periphery. c Speed in the round beam test, measure as decimeters travelled per second. d Number of slippages (errors) per 10 cm in the round beam test. Error bars represent ± SEM. *, #p < 0.05; **p < 0.01; ###p < 0.001

Back to article page